Clinical Trial Update: Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating GW815SF for chronic obstructive pulmonary disease (including chronic bronchitis and emphysema) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• GW815SF

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED